164 related articles for article (PubMed ID: 7504042)
1. A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard.
España F; Sanchez-Cuenca J; Vera CD; Estelles A; Gilabert J
J Lab Clin Med; 1993 Dec; 122(6):711-9. PubMed ID: 7504042
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma.
España F; Estellés A; Fernández PJ; Gilabert J; Sánchez-Cuenca J; Griffin JH
Thromb Haemost; 1993 Dec; 70(6):989-94. PubMed ID: 8165623
[TBL] [Abstract][Full Text] [Related]
3. The interaction among protein C inhibitor, prostate-specific antigen, and the semenogelin system.
Suzuki K; Kise H; Nishioka J; Hayashi T
Semin Thromb Hemost; 2007 Feb; 33(1):46-52. PubMed ID: 17253189
[TBL] [Abstract][Full Text] [Related]
4. The role of protein C inhibitor in human reproduction.
España F; Navarro S; Medina P; Zorio E; Estellés A
Semin Thromb Hemost; 2007 Feb; 33(1):41-5. PubMed ID: 17253188
[TBL] [Abstract][Full Text] [Related]
5. Measurement of protein C inhibitor in seminal plasma is useful for detecting agenesis of seminal vesicles or the vas deferens.
Kise H; Nishioka J; Satoh K; Okuno T; Kawamura J; Suzuki K
J Androl; 2000; 21(2):207-12. PubMed ID: 10714814
[TBL] [Abstract][Full Text] [Related]
6. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
Robert M; Gibbs BF; Jacobson E; Gagnon C
Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810
[TBL] [Abstract][Full Text] [Related]
7. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen.
España F; Gilabert J; Estellés A; Romeu A; Aznar J; Cabo A
Thromb Res; 1991 Nov; 64(3):309-20. PubMed ID: 1725227
[TBL] [Abstract][Full Text] [Related]
8. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.
Laurell M; Christensson A; Abrahamsson PA; Stenflo J; Lilja H
J Clin Invest; 1992 Apr; 89(4):1094-101. PubMed ID: 1372913
[TBL] [Abstract][Full Text] [Related]
9. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen.
Christensson A; Lilja H
Eur J Biochem; 1994 Feb; 220(1):45-53. PubMed ID: 7509746
[TBL] [Abstract][Full Text] [Related]
10. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.
Peracaula R; Tabarés G; Royle L; Harvey DJ; Dwek RA; Rudd PM; de Llorens R
Glycobiology; 2003 Jun; 13(6):457-70. PubMed ID: 12626390
[TBL] [Abstract][Full Text] [Related]
11. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
12. Complexes of tissue kallikrein with protein C inhibitor in human semen and urine.
España F; Fink E; Sanchez-Cuenca J; Gilabert J; Estellés A; Witzgall K
Eur J Biochem; 1995 Dec; 234(2):641-9. PubMed ID: 8536714
[TBL] [Abstract][Full Text] [Related]
13. Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.
Zhang WM; Finne P; Leinonen J; Stenman UH
Scand J Clin Lab Invest Suppl; 2000; 233():51-8. PubMed ID: 11317942
[TBL] [Abstract][Full Text] [Related]
14. [Examination and significance of semenial prostate specific antigen in infertile patients].
Yang GZ; Zhu PY; Hu YA; Ge YF
Zhonghua Nan Ke Xue; 2003 Nov; 9(8):596-8. PubMed ID: 14689894
[TBL] [Abstract][Full Text] [Related]
15. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
España F; Estelles A; Griffin JH; Aznar J
Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
[TBL] [Abstract][Full Text] [Related]
16. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
Tajiri M; Ohyama C; Wada Y
Glycobiology; 2008 Jan; 18(1):2-8. PubMed ID: 17956937
[TBL] [Abstract][Full Text] [Related]
17. Characterization of semenogelin II and its molecular interaction with prostate-specific antigen and protein C inhibitor.
Kise H; Nishioka J; Kawamura J; Suzuki K
Eur J Biochem; 1996 May; 238(1):88-96. PubMed ID: 8665956
[TBL] [Abstract][Full Text] [Related]
18. Purification of human prostatic-specific antigen (hPSA) from seminal plasma by immunoaffinity chromatography using a monoclonal antibody anti total PSA.
Pérez L; Zulueta O; Melchor A; Hernández L; López R; Cazanave J; Béquer D
Hybridoma (Larchmt); 2011 Jun; 30(3):247-51. PubMed ID: 21707359
[TBL] [Abstract][Full Text] [Related]
19. Functionally inactive protein C inhibitor in seminal plasma may be associated with infertility.
He S; Lin YL; Liu YX
Mol Hum Reprod; 1999 Jun; 5(6):513-9. PubMed ID: 10340997
[TBL] [Abstract][Full Text] [Related]
20. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
